Abstract
Despite ongoing research and new insights into the pathophysiological pathways of neonatal hypoxic-ischemic reperfusion brain injury, effective treatment is not yet available. This review briefly covers the mechanisms of hypoxicischemic reperfusion injury and focuses on promising pharmacological neuroprotective strategies which may become available for clinical use in the near future. Furthermore, the beneficial effects of early intervention and combination therapy with moderate hypothermia are discussed.
Keywords: Newborn, Hypoxia-ischemia, Reperfusion injury of the brain, Neuroprotection
Current Pediatric Reviews
Title: Pharmacological Treatment of Hypoxic-Ischemic Reperfusion Injury of the Newborn Brain in the Clinical Setting: What are the Possibilities in the Near Future?
Volume: 2 Issue: 1
Author(s): Helen Torrance, Manon Benders and Frank v. Bel
Affiliation:
Keywords: Newborn, Hypoxia-ischemia, Reperfusion injury of the brain, Neuroprotection
Abstract: Despite ongoing research and new insights into the pathophysiological pathways of neonatal hypoxic-ischemic reperfusion brain injury, effective treatment is not yet available. This review briefly covers the mechanisms of hypoxicischemic reperfusion injury and focuses on promising pharmacological neuroprotective strategies which may become available for clinical use in the near future. Furthermore, the beneficial effects of early intervention and combination therapy with moderate hypothermia are discussed.
Export Options
About this article
Cite this article as:
Torrance Helen, Benders Manon and Bel v. Frank, Pharmacological Treatment of Hypoxic-Ischemic Reperfusion Injury of the Newborn Brain in the Clinical Setting: What are the Possibilities in the Near Future?, Current Pediatric Reviews 2006; 2 (1) . https://dx.doi.org/10.2174/157339606775518296
DOI https://dx.doi.org/10.2174/157339606775518296 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cannabinoid Signaling in Glial Cells in Health and Disease
Current Neuropharmacology The Role of Heat Shock Protein 90 and Endothelial Nitric Oxide Synthase Signaling in Cardiovascular Therapy
Current Signal Transduction Therapy Biosynthesis and Biological Activities of In Vitro Derived Solasodine Glycoalkaloids from <i>Solanum laciniatum</i>
The Natural Products Journal Heparins with Reduced Anti-Coagulant Activity Reduce Myocardial Reperfusion Injury
Recent Patents on Cardiovascular Drug Discovery Low - Molecular Weight Heparins and Unfractionated Heparins during Primary Coronary Intervention
Cardiovascular & Hematological Agents in Medicinal Chemistry Reactive Oxygen and Nitrogen Species in the Renal Ischemia/Reperfusion Injury
Current Pharmaceutical Design Tamoxifen as a Powerful Neuroprotectant in Experimental Stroke and Implications for Human Stroke Therapy
Recent Patents on CNS Drug Discovery (Discontinued) Meet Our Editorial Board Member
Current Pharmaceutical Biotechnology Peroxisome Proliferator-Activated Receptor-α Activation Protects Brain Capillary Endothelial Cells from Oxygen-Glucose Deprivation-Induced Hyperpermeability in the Blood-Brain Barrier
Current Neurovascular Research Eltrombopag Induced Thrombosis: A Case with Acute Myocardial Infarction
Current Drug Safety Development of Novel Cardiovascular Therapeutics From Small Regulatory RNA Molecules - An Outline of Key Requirements
Current Pharmaceutical Design Beneficial Neurobiological Effects of Melatonin Under Conditions of Increased Oxidative Stress
Current Medicinal Chemistry - Central Nervous System Agents Mitochondria as Targets for Neuronal Protection Against Excitotoxicity: A Role for Phenolic Compounds?
Central Nervous System Agents in Medicinal Chemistry Cellular Delivery In Vivo of siRNA-Based Therapeutics
Current Pharmaceutical Design Pleiotropic Effects of Cytokines on Acute Myocardial Infarction: G-CSF as A Novel Therapy for Acute Myocardial Infarction
Current Pharmaceutical Design Antiviral Profile of HIV Inhibitors in Macrophages: Implications for Therapy
Current Topics in Medicinal Chemistry Pharmacotherapy of Sickle Cell Disease in Children
Current Pharmaceutical Design Potential Roles of HDAC Inhibitors in Mitigating Ischemia-induced Brain Damage and Facilitating Endogenous Regeneration and Recovery
Current Pharmaceutical Design Therapeutic Potential of Targeting TREM-1 in Inflammatory Diseases and Cancer
Current Pharmaceutical Design Nesfatin-1 and the Cardiovascular System: Central and Pheripheral Actions and Cardioprotection
Current Drug Targets